For contract research organizations (CROs), randomization and supply management solutions can often be cumbersome and negatively impact trial timelines, costs and sponsor and patient relationships. But there’s a new way to handle clinical supply management on the horizon that will put the control back in your hands. The industry has been yearning for a change, calling for self-service configuration, simple user interface, and expedited trial set-up, and that change is here.
Join Oracle as their speakers discuss the future of randomization and trial supply management and how these fundamental shifts will allow you to save time and money for your sponsors.
Dr. MaryAnne Rizk, Global Vice President, CRO & Biopharma Business Partnerships & Alliances, Oracle Health Sciences
Dr. MaryAnne Rizk globally leads the CRO Business Partnership strategy at Oracle Health Sciences. Prior to joining Oracle, MaryAnne was the Senior Director at Medidata’s CRO Partner program, leading the eClinical SaaS business through accredited CROs Channel partners. At Merck, MaryAnne had led both global clinical and commercial technology initiatives, including the collaborative Merck & Schering Plough joint venture and the deployment of Merck’s global clinical trial portal for principal investigators, and managed clinical outsourcing activities to key stakeholders of CROs, SIs and technology vendors.
Dr. Rizk received her Bachelor of Engineering and Masters in Management from Stevens Institute of Technology. She holds a PhD in Technology Management specializing her dissertation in Pharmaceutical Strategic Partnerships. Dr. Rizk is an active leader and speaker of Healthcare Innovation through chairing various board memberships and is a proud member of the following networks: Healthcare Businesswoman’s Association (HBA), New York Health Business Leaders (NYHBL), and the Drug Information Association (DIA).
Global Health Science Alliance Strategist innovating Clinical Organizations on cloud-based technologies and leveraging Big Data analytics to build strategic outsourcing partnerships in Pharma and Medical Device to improve Patient Health-Outcomes.
Jennifer Bush, Director, Product Strategy, Oracle Health Sciences
Jennifer Bush is a life sciences professional with over 19 years of industry experience in both business and IT environments. Jennifer has worked in large pharma, large CRO and IT. She has worked in both business and IT departments managing data transformation and loading, eClinical implementations including implementation of EDC, clinical trial management and other clinical systems. Jennifer now works as a Life Sciences Product Strategist at Oracle focusing on clinical trial planning, management and monitoring offerings, including risk based monitoring.
David Shuford, Senior Solutions Consultant, Oracle Health Sciences
David Shuford, a Senior Solutions Consultant, has been with the Oracle HSGBU since the acquisition of PhaseForward in 2010. He supports HSGBU North American Sales of the eClinical suite of products with a focus on Electronic Data Capture, Interactive Response Technology, Siebel Clinical Trial Management System, Clinical Data Analytics, and Risk-based Monitoring solutions.
Who Should Attend?
- Pharmaceutical and Biotechnology Companies
- Medical Device Manufacturers
- Healthcare Institutions
VPs, Directors and Heads of:
- Clinical Data / Data Standards / Biostatistics
- Clinical Development
- Clinical Operations
- Data Science
- Randomization / Supply Management
- Statistical Programming
- Strategic Planning/ Business Development
What You Will Learn
- New ways to reduce complexity, dependency and process time around randomization and supplies management
- New choices and approaches for tackling your randomization needs
- The shift to self-service, user friendly interfaces and configurable technology